For those on blood thinners
Ahead of vaccinating those aged over 50 and with comorbidities, the makers of Covishield and Covaxin have written to the drugs regulator asking for a change in the advisory that those on blood thinners should not take the vaccine. “The relative contraindications regarding the blood thinners are mentioned in both the vaccines and we have written to the DCGI (Drugs Controller General of India) to change this point in the fact sheet,” Balram Bhargava, director general, Indian Council of Medical Research (ICMR), said.
Bhargava said there was no reason to worry for those who are on anti-platelets blood thinner such as Aspirin. For patients who are on anticoagulants such as Heparin, the only concern is that their tendency to bleed is higher and that they may experience swelling on the injection site. He said in these cases, the medication can be stopped two days before the vaccine is given. “This will be rectified in the fact sheet very soon as soon as the regulator gives the approval,” Bhargava added.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)